These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 16864840)

  • 41. Vanishing white matter disease caused by EIF2B2 mutation with the presentation of an adrenoleukodystrophy phenotype.
    Alsalem A; Shaheen R; Alkuraya FS
    Gene; 2012 Apr; 496(2):141-3. PubMed ID: 22285377
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Novel myelin protein zero mutation (Arg36Trp) in a patient with acute onset painful neuropathy.
    Burns TM; Phillips LH; Dimberg EL; Vaught BK; Klein CJ
    Neuromuscul Disord; 2006 May; 16(5):308-10. PubMed ID: 16616847
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ovarioleukodystrophy due to EIF2B5 mutations.
    Ibitoye RT; Renowden SA; Faulkner HJ; Scolding NJ; Rice CM
    Pract Neurol; 2016 Dec; 16(6):496-499. PubMed ID: 27651498
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Corticosteroid-responsive dominantly inherited neuropathy in childhood.
    Bird SJ; Sladky JT
    Neurology; 1991 Mar; 41(3):437-9. PubMed ID: 1848688
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Demyelinating peripheral neuropathy with Creutzfeldt-Jakob disease and mutation at codon 200 of the prion protein gene.
    Antoine JC; Laplanche JL; Mosnier JF; Beaudry P; Chatelain J; Michel D
    Neurology; 1996 Apr; 46(4):1123-7. PubMed ID: 8780103
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
    Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
    Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter].
    Pronk JC; Leegwater PA; van der Knaap MS
    Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Demyelinating disease of central and peripheral nervous systems associated with a A8344G mutation in tRNALys.
    Erol I; Alehan F; Horvath R; Schneiderat P; Talim B
    Neuromuscul Disord; 2009 Apr; 19(4):275-8. PubMed ID: 19269823
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Congenital hypomyelinating neuropathy, a long term follow-up study in an affected family.
    Smit LS; Roofthooft D; van Ruissen F; Baas F; van Doorn PA
    Neuromuscul Disord; 2008 Jan; 18(1):59-62. PubMed ID: 17825553
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Genetic and clinical heterogeneity in eIF2B-related disorder.
    Maletkovic J; Schiffmann R; Gorospe JR; Gordon ES; Mintz M; Hoffman EP; Alper G; Lynch DR; Singhal BS; Harding C; Amartino H; Brown CM; Chan A; Renaud D; Geraghty M; Jensen L; Senbil N; Kadom N; Nazarian J; Yuanjian Feng ; Zuyi Wang ; Hartka T; Morizono H; Vanderver A
    J Child Neurol; 2008 Feb; 23(2):205-15. PubMed ID: 18263758
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Demyelinating disease affecting both central and peripheral nervous system].
    Carra-Dallière C; Mania A; Carlander B; Camu W; Juntas-Morales R
    Rev Neurol (Paris); 2011 Dec; 167(12):921-5. PubMed ID: 21596409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Multiple Sclerosis and EIF2B5: A Paradox or a Missing Link.
    Zahoor I; Haq E; Asimi R
    Adv Exp Med Biol; 2017; 958():57-64. PubMed ID: 28093708
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The dominant form of vanishing white matter-like leukoencephalopathy represents autosomal dominant leukodystrophy.
    Ptácek LJ; Fu YH; Koeppen A
    Ann Neurol; 2006 Feb; 59(2):434. PubMed ID: 16437562
    [No Abstract]   [Full Text] [Related]  

  • 54. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
    Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
    Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Arg113His mutation in eIF2Bepsilon as cause of leukoencephalopathy in adults.
    van der Knaap MS; Leegwater PA; van Berkel CG; Brenner C; Storey E; Di Rocco M; Salvi F; Pronk JC
    Neurology; 2004 May; 62(9):1598-600. PubMed ID: 15136689
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [What is a peripheral neuropathy?].
    Magy L
    Rev Prat; 2008 Nov; 58(17):1873-7, 1880-1. PubMed ID: 19157202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Novel SACS mutation in a Belgian family with sacsin-related ataxia.
    Ouyang Y; Segers K; Bouquiaux O; Wang FC; Janin N; Andris C; Shimazaki H; Sakoe K; Nakano I; Takiyama Y
    J Neurol Sci; 2008 Jan; 264(1-2):73-6. PubMed ID: 17716690
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hereditary motor and sensory neuropathy caused by a novel mutation in LITAF.
    Gerding WM; Koetting J; Epplen JT; Neusch C
    Neuromuscul Disord; 2009 Oct; 19(10):701-3. PubMed ID: 19541485
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Peripheral neuropathy--a novel finding in dyskeratosis congenita.
    Ip P; Knight R; Dokal I; Manzur AY; Muntoni F
    Eur J Paediatr Neurol; 2005; 9(2):85-9. PubMed ID: 15843075
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Vanishing white matter disease in a child presenting with ataxia.
    Wilson CJ; Pronk JC; Van der Knaap MS
    J Paediatr Child Health; 2005; 41(1-2):65-7. PubMed ID: 15670229
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.